(ALCRB) Carbios - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0011648716
ALCRB EPS (Earnings per Share)
ALCRB Revenue
ALCRB: Enzymatic Recycling, Biodegradation Solutions, Exported Products
Carbios SAS is a French company that has been pioneering the development of enzymatic processes for plastic recycling and biodegradation since its inception in 2011. Headquartered in Clermont-Ferrand, France, Carbios has established itself as a key player in the field of sustainable plastics management. The companys innovative approach to enzymatic recycling enables the breakdown of plastic waste into raw materials that can be reused, thereby reducing the environmental impact of plastic pollution.
With a strong focus on research and development, Carbios has successfully developed proprietary enzymes that can degrade plastic at a significantly faster rate than natural processes. This technology has the potential to revolutionize the plastics industry by providing a more efficient and environmentally friendly method of plastic waste management. The companys products and technologies are not limited to the French market, as it exports its solutions to a global clientele.
From a technical analysis perspective, the stock has shown significant volatility, with a 52-week high of €25.80 and a low of €4.99. Currently, the stock is trading at €6.38, below its 20-day Simple Moving Average (SMA) of €6.86, but above its 50-day SMA of €6.37. The Average True Range (ATR) of 0.52 indicates a relatively high level of price volatility. Given the current technical setup, it is likely that the stock will continue to consolidate around its current price levels before making a significant move.
Fundamentally, Carbios has a market capitalization of €127.61M and a negative Return on Equity (RoE) of -31.55%, indicating that the company is currently operating at a loss. The absence of a Price-to-Earnings (P/E) ratio further emphasizes the companys current unprofitable state. However, this is not uncommon for companies in the development stage, particularly those in the biotechnology and cleantech sectors, where significant upfront investments are required to drive innovation and growth.
Forecasting the future performance of ALCRB requires a comprehensive analysis of both technical and fundamental data. While the current technical setup suggests a period of consolidation, the long-term prospects of the company are closely tied to its ability to commercialize its enzymatic recycling technology and achieve profitability. If Carbios can successfully scale its operations and secure significant contracts or partnerships, we could see a substantial increase in its stock price. Conversely, failure to achieve these milestones could result in continued volatility and potentially further declines. Based on the current data, a potential target price for ALCRB could be in the range of €8-€12, assuming the company can achieve significant milestones in the next 12-18 months. However, this forecast is subject to a high degree of uncertainty and should be closely monitored as new information becomes available.
Additional Sources for ALCRB Stock
ALCRB Stock Overview
Market Cap in USD | 138m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception |
ALCRB Stock Ratings
Growth Rating | -66.9 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -65 |
Analysts | - |
Fair Price Momentum | 5.48 EUR |
Fair Price DCF | - |
ALCRB Dividends
Currently no dividends paidALCRB Growth Ratios
Growth Correlation 3m | 66.6% |
Growth Correlation 12m | -78% |
Growth Correlation 5y | -76.4% |
CAGR 5y | -13.95% |
CAGR/Max DD 5y | -0.15 |
Sharpe Ratio 12m | -0.73 |
Alpha | -76.57 |
Beta | 0.841 |
Volatility | 67.54% |
Current Volume | 27.8k |
Average Volume 20d | 33.3k |
As of June 24, 2025, the stock is trading at EUR 6.99 with a total of 27,776 shares traded.
Over the past week, the price has changed by -6.61%, over one month by +11.31%, over three months by +14.78% and over the past year by -65.40%.
No, based on ValueRay´s Analyses, Carbios (PA:ALCRB) is currently (June 2025) a stock to sell. It has a ValueRay Growth Rating of -66.92 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALCRB is around 5.48 EUR . This means that ALCRB is currently overvalued and has a potential downside of -21.6%.
Carbios has no consensus analysts rating.
According to our own proprietary Forecast Model, ALCRB Carbios will be worth about 6.2 in June 2026. The stock is currently trading at 6.99. This means that the stock has a potential downside of -11.16%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 21.7 | 210% |
Analysts Target Price | - | - |
ValueRay Target Price | 6.2 | -11.2% |